Notoriously behind the times, the FDA has made moves to nurture and regulate healthcare innovation. But what will happen now that commissioner Scott Gottlieb, M.D., has resigned? We explore the FDA’s history and then discuss its future and Gottlieb’s legacy with Arti Rai, J.D., of Duke Law’s Center for Innovation Policy.

Get more great insights from Inside Digital Health & MedTech Boston.